Will Strong TASER Demand Continue to Guide Axon's Connected Devices Unit?

Axon Enterprise's Connected Devices segment saw revenues increase 26.1% year-over-year in Q1 2025, primarily driven by strong demand for TASER 10 products, which led to a $30.9 million increase in TASER-related revenue. The segment also benefited from increased sales of body-worn cameras, VR training services, and counter-drone equipment. Axon's stock has surged 165.2% in the past year, significantly outperforming the industry's growth of 42.1%, while its forward price-to-earnings ratio stands at 1,156.40X, substantially above the industry average of 46.32X.

Analysis

Axon Enterprise's Connected Devices segment reported a significant 26.1% year-over-year revenue increase in Q1 2025, driven by robust demand for its TASER 10 products, which alone accounted for a $30.9 million revenue uplift. This growth was further supported by strong uptake of the Axon Body 4 camera, launched in April 2023, alongside expanding sales in VR training, counter-drone technology, and increased warranty revenues from a larger deployed base. The company's stock has appreciated 165.2% in the past year, substantially outpacing the industry's 42.1% growth. Despite this strong operational performance and an upward trend in the Zacks Consensus Estimate for Q2 2025 earnings, Axon trades at a very high forward price-to-earnings ratio of 1,156.40X, far exceeding the industry average of 46.32X, and carries a Zacks Value Score of F. This suggests that while the underlying business fundamentals and market demand, fueled by global security concerns, appear strong and position the segment for sustained momentum, the current market valuation is considerably stretched. Comparatively, peers like Kratos Defense & Security Solutions and Teledyne Technologies reported more modest growth in their relevant segments, with Kratos's Government Solutions segment increasing revenues by 10% YoY and Teledyne's Digital Imaging segment by 2.2% YoY.

Key Decisions for Investors

• Investors should acknowledge Axon's robust revenue growth and product innovation within a favorable market but exercise significant caution due to its exceptionally high valuation metrics, particularly the forward P/E ratio of 1,156.40X and the F Value Score.
• While rising earnings estimates and strong demand for public safety technologies provide a positive backdrop, the current stock price, having surged 165.2% in the past year, may have already priced in substantial future growth, warranting close monitoring for any deceleration or shifts in market sentiment.
• Given the Zacks Rank #3 (Hold) and extreme valuation, investors might consider holding existing positions if aligned with a high-growth strategy but should be wary of initiating or adding to positions without a thorough assessment of the risk-reward profile at these levels.